Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",43046,236,1.58 [1.05-2.38],0.0287786119397504
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",44530,336,0.86 [0.59-1.25],0.4236249269493286
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",44081,2329,1.32 [1.15-1.52],6.216661340159735e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,44565,723,1.47 [1.16-1.88],0.0017687922029802
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,43219,5954,1.13 [1.03-1.23],0.0074404537978667
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),43412,5414,1.28 [1.17-1.40],1.0295598158925985e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,44137,2062,0.98 [0.84-1.14],0.7676636536431249
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,44411,149,0.92 [0.52-1.61],0.758234164645316
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,41087,1617,1.50 [1.27-1.76],9.539304943805545e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,39647,1796,1.43 [1.23-1.67],5.768137141794062e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,39526,426,1.69 [1.24-2.29],0.0008101262695478
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,31295,3335,1.27 [1.13-1.42],6.651849997639259e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,39263,653,1.36 [1.05-1.77],0.0184429279035263
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,44500,2425,1.00 [0.87-1.15],0.9799681555430088
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Mycoses,44695,853,1.39 [1.11-1.74],0.0042899470889827
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,43308,1556,1.31 [1.11-1.55],0.0014692778961909
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,44591,1781,1.50 [1.29-1.74],1.8636096493347405e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,42413,338,0.85 [0.58-1.24],0.3960137248053952
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,44788,81,1.12 [0.53-2.38],0.760986525238378
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,44369,1559,1.51 [1.28-1.77],6.962312446507325e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,44391,129,0.86 [0.47-1.55],0.6086346815522812
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,44643,268,1.28 [0.84-1.93],0.2464416219453836
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",44614,239,1.35 [0.88-2.09],0.1738586508092952
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,42447,695,1.50 [1.17-1.91],0.0012596102377806
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,42218,466,0.92 [0.67-1.26],0.598209890082338
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,42245,170,1.33 [0.80-2.22],0.2655185829172581
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,44746,93,1.12 [0.57-2.23],0.7424301204660989
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,44671,268,1.15 [0.76-1.74],0.5200884005535371
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral warts,44492,89,1.10 [0.53-2.26],0.79940320245098
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],44519,116,1.23 [0.66-2.31],0.5189505612282681
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm,44276,510,1.04 [0.77-1.40],0.8187201836734206
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,44636,106,0.87 [0.44-1.69],0.6736004074042674
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,44592,109,0.81 [0.42-1.56],0.5255304492884861
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20524,107,1.23 [0.64-2.35],0.5302154681047124
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",44209,2482,0.83 [0.72-0.96],0.0094015328299304
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of meninges,44763,100,0.72 [0.36-1.45],0.3602740927883615
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,44673,118,0.77 [0.41-1.46],0.4307236576145705
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,44742,184,0.96 [0.58-1.58],0.8589122913651108
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of ovary,24158,150,0.73 [0.41-1.30],0.2836049275824766
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,44745,635,0.92 [0.70-1.20],0.5292024845612919
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Caecum,44753,518,0.88 [0.65-1.19],0.4041940583213769
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",44596,122,0.89 [0.48-1.66],0.7234820206141135
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,44746,381,0.75 [0.53-1.07],0.1075292755367081
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Rectum,44670,615,0.90 [0.68-1.19],0.4677709986820894
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,44579,1083,0.91 [0.74-1.12],0.3771077555190862
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,44736,730,0.95 [0.74-1.22],0.6968675589552904
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Carcinoma in situ of breast,19600,119,0.99 [0.52-1.88],0.9709115976509084
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19673,140,0.85 [0.47-1.55],0.6035474324164789
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",35674,93,1.83 [0.99-3.39],0.0538568783066493
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",35699,118,1.35 [0.74-2.46],0.3303209825939294
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",44695,206,1.38 [0.87-2.21],0.1706424407086686
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Haemangioma, any site",44696,201,1.35 [0.84-2.17],0.2083610240099946
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Leiomyoma of uterus,23347,511,0.86 [0.63-1.17],0.323594765222769
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Lung cancer and mesothelioma,31106,592,1.93 [1.45-2.57],6.73037399534504e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Lymphoid leukaemia,35671,90,1.71 [0.89-3.27],0.1073569558185578
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",35905,324,0.96 [0.65-1.41],0.8331177638165301
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",35921,340,1.04 [0.72-1.50],0.8309350497037712
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19806,170,1.04 [0.61-1.75],0.8930592229372825
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",35725,144,1.16 [0.67-2.01],0.595426950072671
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",35759,178,0.75 [0.45-1.26],0.2805269939691592
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",35757,176,1.25 [0.77-2.04],0.3730794398176387
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19767,131,2.10 [1.25-3.52],0.0050707710105486
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",35744,163,0.78 [0.46-1.33],0.3616450244447805
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",17129,1184,0.85 [0.70-1.03],0.1029814064417605
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",35784,203,1.09 [0.68-1.75],0.7170809495209292
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",35710,129,1.16 [0.65-2.08],0.6099240411207545
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,35759,178,1.47 [0.91-2.40],0.1177670462102082
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanocytic naevi,44454,355,0.97 [0.67-1.40],0.8623848736732608
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanocytic naevi of trunk,44720,154,1.07 [0.61-1.86],0.8183789383775215
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanoma in situ,35640,141,0.83 [0.46-1.49],0.5309712254249439
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",35740,159,1.62 [0.99-2.65],0.0568360289585032
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",35859,278,1.28 [0.86-1.90],0.2270237793233969
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",35988,407,1.56 [1.15-2.10],0.0038497388138433
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",35754,173,1.38 [0.84-2.25],0.2004833258544952
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Other benign neoplasms of skin,44474,278,1.07 [0.71-1.61],0.7421472260424062
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",37426,1845,1.01 [0.86-1.19],0.8848849296557413
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",37523,1942,1.03 [0.88-1.20],0.7312994593335761
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,44274,594,1.54 [1.18-2.01],0.0016348856611477
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,41590,154,1.56 [0.93-2.61],0.0931965362314304
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,43809,129,1.22 [0.68-2.21],0.5044748614605976
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,43451,4921,1.04 [0.94-1.15],0.4433802417724637
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,42327,82,1.41 [0.70-2.84],0.3384970707818786
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,44078,88,1.09 [0.53-2.23],0.8173030033826216
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,43979,2543,1.07 [0.93-1.22],0.3488891195670166
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,43977,2541,1.07 [0.93-1.22],0.3504673034956966
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,41583,147,1.42 [0.82-2.46],0.205479619335164
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,44239,1994,1.02 [0.88-1.19],0.7778054683656016
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,44185,195,1.40 [0.87-2.24],0.1652834784867882
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,43789,109,1.84 [1.03-3.30],0.0394886974209129
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,43788,108,1.56 [0.84-2.90],0.1584657065815514
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,44457,467,1.53 [1.14-2.06],0.0049048517228635
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,44608,92,0.70 [0.34-1.42],0.3235635641421173
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",44378,388,1.60 [1.16-2.21],0.0041833459088106
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,42419,174,0.61 [0.36-1.04],0.0680871684068652
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,34782,520,1.52 [1.16-2.00],0.0026024778440143
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,41758,196,1.33 [0.83-2.10],0.2322559734831728
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,41786,224,1.71 [1.12-2.61],0.0121624263805296
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,34354,92,2.38 [1.38-4.12],0.0018824914212244
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,41627,106,1.65 [0.89-3.08],0.1131235962479864
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,40682,397,0.95 [0.67-1.35],0.7801416031136545
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",44008,910,1.24 [1.00-1.54],0.0554530467616501
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,43559,461,1.36 [1.00-1.85],0.0470398199451114
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,43278,180,0.96 [0.58-1.60],0.8782205966011424
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,44194,2673,1.09 [0.96-1.25],0.1878288930473515
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,39120,2603,1.12 [0.98-1.28],0.1017892353662523
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",34370,108,1.94 [1.12-3.38],0.0183403577874009
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",41381,138,1.09 [0.61-1.94],0.7795185622523524
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,34737,475,1.17 [0.86-1.59],0.327822126249301
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,34365,103,2.21 [1.28-3.81],0.0042736159037615
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,40332,6070,1.10 [1.01-1.20],0.0313182745427142
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,34604,342,1.71 [1.22-2.38],0.0016514872473914
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,35213,951,1.47 [1.19-1.81],0.0003087608992562
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,44653,540,0.99 [0.74-1.33],0.9706768418064332
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,44329,216,1.02 [0.64-1.63],0.9303242784175486
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,34482,220,1.85 [1.24-2.77],0.0027045287780398
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",34366,104,1.36 [0.72-2.57],0.3443450590638657
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,43860,2617,1.06 [0.93-1.21],0.3931180709783534
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,34689,427,1.83 [1.39-2.41],1.7606704932697956e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,34725,463,1.31 [0.98-1.77],0.0722878193010853
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",35344,1082,1.17 [0.96-1.43],0.1235420785458635
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,34451,189,1.37 [0.86-2.18],0.1872210050416745
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,44318,205,1.08 [0.67-1.73],0.7570965247755906
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,35293,1031,1.54 [1.26-1.87],2.264167777163073e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,35095,833,1.42 [1.13-1.77],0.0025271272316219
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,40397,112,2.32 [1.34-4.02],0.0027381665643489
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,42835,8573,1.17 [1.09-1.25],2.920427984327189e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,41320,77,0.69 [0.32-1.53],0.3643180230194187
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,41343,100,0.74 [0.37-1.48],0.3930812397522595
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,44479,3326,1.00 [0.89-1.12],0.9631620138293202
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",44479,3320,1.00 [0.89-1.12],0.9726638873042426
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,41328,85,1.13 [0.54-2.36],0.7415554957437991
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,44194,2088,1.20 [1.04-1.40],0.0150449927221205
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",36936,2674,1.39 [1.22-1.57],3.105266851379139e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,44768,362,1.70 [1.23-2.34],0.0011996609739146
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,43226,128,1.01 [0.56-1.83],0.9766856356167456
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,42291,185,1.29 [0.79-2.11],0.3159606813741983
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,42352,246,0.65 [0.42-1.02],0.0618321156055901
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",34535,273,0.77 [0.50-1.18],0.2358434473188222
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,40787,266,2.02 [1.43-2.86],7.551565339298853e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3670,144,1.51 [0.89-2.59],0.1289754362748122
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3900,420,0.90 [0.65-1.23],0.5013632358901172
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,40628,107,1.26 [0.68-2.31],0.4644394952697892
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3608,83,1.09 [0.54-2.23],0.808661972812181
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,43722,3201,1.24 [1.10-1.38],0.0002658247066252
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,43669,571,1.05 [0.79-1.40],0.7273565062967007
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,40904,619,1.20 [0.92-1.57],0.1857521228045326
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,35544,1282,1.25 [1.04-1.50],0.0190790159948475
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",44588,416,1.25 [0.90-1.74],0.1786962048700864
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),42867,280,1.30 [0.88-1.92],0.1898443277368684
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Angina pectoris,40972,2024,1.21 [1.05-1.41],0.0098978519845303
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,43001,414,1.27 [0.92-1.76],0.1457435861941202
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,42684,97,2.19 [1.23-3.89],0.0075461026325172
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",42920,333,2.17 [1.59-2.95],8.270314310761764e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,27790,3241,1.42 [1.25-1.60],2.5249772793189066e-08
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,AV-block,37839,724,1.01 [0.78-1.30],0.9377041319492916
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",44688,713,1.13 [0.88-1.45],0.3480454152067157
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,24872,323,1.81 [1.22-2.66],0.0028987218200013
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,37409,294,1.31 [0.88-1.93],0.1780611323637139
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",37281,166,1.06 [0.62-1.81],0.8288431443934879
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,44785,78,1.43 [0.69-2.96],0.3364262787821563
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Conduction disorders,38901,1786,1.16 [0.98-1.36],0.0777993518222134
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,42478,3561,1.24 [1.11-1.38],0.0001760995743928
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,39216,13169,1.09 [1.02-1.16],0.0056362432495869
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,42420,450,1.33 [0.97-1.83],0.0795496044849259
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Endocarditis,37232,117,1.70 [0.95-3.02],0.0719862615595465
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",44430,1861,1.58 [1.37-1.83],4.763539865253813e-10
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypertension,40785,11262,1.02 [0.96-1.09],0.4846141752298957
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",40798,11275,1.02 [0.96-1.09],0.4975326145222822
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",44488,133,2.56 [1.68-3.90],1.325294323193964e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29845,322,3.32 [2.69-4.09],2.143602579756993e-29
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,29691,168,1.30 [0.79-2.14],0.3109832696136275
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypotension,44546,1945,1.39 [1.20-1.61],1.334030643355928e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,43224,182,0.99 [0.60-1.65],0.9767771843564556
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",42779,3831,1.19 [1.07-1.33],0.0012918569447482
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",44163,960,1.18 [0.95-1.46],0.1352391637803519
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,37736,621,1.45 [1.11-1.88],0.0056505073371564
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,43997,1445,1.17 [0.98-1.39],0.0861192529331625
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",40164,1216,1.16 [0.96-1.41],0.1194032065585226
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",44626,274,1.44 [0.98-2.13],0.0648823292878655
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",44737,533,1.16 [0.87-1.55],0.3116176999364842
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,42060,90,2.80 [1.52-5.17],0.0009948983871033
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other aneurysm,42714,127,2.10 [1.25-3.55],0.0052804558712459
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,37844,729,1.29 [1.01-1.66],0.0414641019369452
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,42756,169,1.96 [1.22-3.13],0.0051444318043416
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,42993,406,1.37 [0.98-1.91],0.0622706422547032
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,37424,309,1.64 [1.14-2.36],0.0074894095911306
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,42122,152,1.78 [1.05-3.02],0.0319167821053949
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,42054,84,0.50 [0.24-1.07],0.075604917966542
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,42361,110,0.92 [0.48-1.76],0.8078506087079866
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,42196,226,1.36 [0.86-2.13],0.185106379142733
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,38847,1732,1.40 [1.20-1.64],2.180187173467293e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,42692,91,1.56 [0.80-3.03],0.1904389822880389
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,43509,922,1.60 [1.29-1.98],1.877646759604464e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,43726,607,2.87 [2.39-3.45],3.352367597607891e-29
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",43278,1027,1.11 [0.90-1.37],0.3276868924786022
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,25115,566,1.70 [1.27-2.28],0.0003256355966453
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,43211,678,1.83 [1.45-2.32],4.146327846608368e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),42552,582,1.25 [0.94-1.66],0.1174610806370768
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,43923,804,1.08 [0.85-1.38],0.5086153721740686
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,44661,1105,1.50 [1.24-1.82],3.0583101991806475e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,37708,593,1.10 [0.83-1.45],0.5145917867255755
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,43718,599,2.84 [2.35-3.42],5.642460238376195e-28
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,42570,319,1.38 [0.96-1.98],0.0847466076596285
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",44139,1097,1.14 [0.93-1.39],0.2067237303374143
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",44104,1164,1.16 [0.95-1.41],0.1503270629913564
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,43178,103,1.46 [0.77-2.80],0.2486801800455992
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,42720,134,1.31 [0.73-2.34],0.360152467298908
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,43589,386,0.99 [0.70-1.40],0.9335924674969696
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,42994,442,1.20 [0.88-1.65],0.2434129716792596
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Varicose veins,42683,713,1.26 [0.98-1.63],0.07473449404845
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,42611,146,1.40 [0.80-2.45],0.2375988727476531
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,44387,1263,1.11 [0.92-1.35],0.2784665397292418
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",44573,623,1.24 [0.95-1.62],0.1210430870415728
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",39261,2464,1.16 [1.01-1.33],0.0338891518514836
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Any mental disorder,43667,6870,1.13 [1.04-1.23],0.0028957927578323
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",44491,728,1.17 [0.91-1.50],0.2267964906165545
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",39521,2724,1.13 [0.99-1.28],0.0761480250334163
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",36940,143,1.05 [0.59-1.85],0.8738189386808681
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Smoking dependency,43859,2381,1.31 [1.15-1.50],6.2324735345215e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",39619,2822,1.23 [1.09-1.40],0.0012329180222527
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Vascular dementia,43966,215,1.27 [0.81-1.98],0.2965697105459374
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Alzheimer disease,44786,575,1.27 [0.96-1.67],0.0933247989133805
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",30376,101,1.88 [1.13-3.14],0.0154505183453375
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Bell's palsy,41720,140,1.76 [1.04-3.00],0.0366348273799359
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,42442,862,1.06 [0.84-1.34],0.613683309508715
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Cerebral cysts,44091,387,1.07 [0.76-1.51],0.7034480689095406
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,44644,530,1.18 [0.88-1.58],0.2656761035786103
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,43948,95,0.85 [0.42-1.73],0.6586899044516901
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,44759,110,1.43 [0.77-2.65],0.2539507684013292
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",43824,120,2.42 [1.46-4.01],0.0006384406169014
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Epilepsy,42133,487,1.56 [1.16-2.10],0.0035233935440891
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,43964,2318,1.16 [1.01-1.33],0.0388759768565483
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,44709,714,0.95 [0.73-1.22],0.6673032052223098
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,43766,4364,1.17 [1.05-1.29],0.0031596293701069
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,44138,93,3.33 [1.99-5.57],4.8224325930650044e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Hemiplegia,44528,414,1.20 [0.86-1.66],0.2817248981312465
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Hydrocephalus,43807,103,1.85 [1.00-3.43],0.0495293124827657
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,44752,117,1.38 [0.75-2.56],0.3001473772414027
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,41712,132,1.05 [0.57-1.93],0.8789997908099801
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,41715,135,1.14 [0.64-2.03],0.666566546009461
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Memory loss,43717,197,1.05 [0.65-1.72],0.8332200440884839
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Migraine,42254,608,1.12 [0.85-1.49],0.4283511128388156
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",44666,550,1.19 [0.89-1.59],0.2507638462156189
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Motor neuron disease,30567,256,1.15 [0.75-1.76],0.5273045422527891
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,44485,186,1.05 [0.63-1.76],0.8433209931973847
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",43642,2062,1.08 [0.93-1.26],0.2925889268458033
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Neurological diseases,42225,6285,1.08 [0.99-1.17],0.099555240670342
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,44166,313,1.11 [0.76-1.63],0.5887463313859558
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",42272,692,0.95 [0.73-1.24],0.7204221630656826
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",44657,497,2.25 [1.75-2.90],2.042283923834057e-10
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,35848,1104,1.20 [0.98-1.47],0.0810423195507774
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,43826,122,0.58 [0.31-1.08],0.0838344252701623
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,43944,240,1.28 [0.84-1.95],0.257976632217032
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,44247,252,1.27 [0.83-1.93],0.2751006559483158
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,41745,165,1.38 [0.82-2.30],0.2235073439766265
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other headache syndromes,41748,102,1.50 [0.79-2.87],0.2186947917963836
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other neurological diseases,44583,879,1.05 [0.83-1.32],0.6810231686918398
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other sleep disorders,42594,948,1.09 [0.88-1.35],0.4449017537426935
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Parkinson's disease,44742,423,0.83 [0.59-1.16],0.2671825521899763
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,43799,95,0.54 [0.26-1.12],0.0975101934064543
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,44784,112,1.48 [0.79-2.76],0.2190794008694927
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Sleep apnoea,44376,821,1.06 [0.84-1.33],0.6139127342380672
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,44243,83,3.25 [2.00-5.29],2.0040073740232524e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,44759,302,1.38 [0.94-2.02],0.1025225333510099
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,41670,90,1.04 [0.50-2.16],0.909139972442741
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,44786,581,1.26 [0.96-1.66],0.0992794397353103
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),43898,208,1.25 [0.79-1.96],0.3438540737463854
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,43811,166,1.18 [0.70-2.00],0.5377639876687474
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,44085,678,1.14 [0.88-1.48],0.3289584305970797
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,44505,394,1.19 [0.86-1.64],0.290336392464759
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,43051,91,1.56 [0.80-3.07],0.192596200590188
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,43064,104,1.45 [0.76-2.79],0.2613804566658639
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",44596,93,1.64 [0.85-3.15],0.1419046432836118
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,44339,255,1.17 [0.77-1.78],0.4601103610256937
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3615,89,1.24 [0.63-2.46],0.5286654299071143
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4370,168,1.69 [1.04-2.72],0.0324072364267456
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,43809,164,1.73 [1.06-2.83],0.0295558882721716
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,44440,1782,1.08 [0.92-1.27],0.3202458275976019
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",44147,1187,1.06 [0.87-1.29],0.5447132296103392
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,43343,383,0.97 [0.68-1.38],0.8610870230737473
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",44647,1240,1.10 [0.90-1.33],0.3586089733145146
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,44773,119,1.57 [0.87-2.84],0.1355693564645137
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,44525,1118,1.03 [0.84-1.26],0.8010933243948742
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",44714,630,1.18 [0.90-1.54],0.2225195907168418
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,44621,318,0.83 [0.56-1.22],0.3434165429460944
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,43064,104,0.65 [0.33-1.28],0.2152439894987627
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,43077,117,1.64 [0.92-2.92],0.0912182591968565
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,43055,95,0.66 [0.32-1.36],0.2625548854090644
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,44627,1215,1.12 [0.93-1.36],0.2376050407179474
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,43734,322,1.02 [0.70-1.49],0.9104258883013407
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,43489,82,0.87 [0.40-1.86],0.7108527146213222
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,44256,172,1.69 [1.04-2.72],0.0323617864555168
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,44555,471,1.14 [0.83-1.55],0.4193794520672785
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,43741,334,0.92 [0.63-1.35],0.6755414901973985
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,44493,190,0.70 [0.42-1.16],0.1629346659821082
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,44204,792,1.18 [0.93-1.49],0.1765738119475642
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,43882,237,1.36 [0.89-2.09],0.1567523294109727
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,42051,3776,1.02 [0.91-1.14],0.71655259067298
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,44497,413,1.11 [0.80-1.55],0.534947289877342
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,44750,265,1.59 [1.08-2.36],0.0197524165146071
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,43661,701,1.06 [0.82-1.37],0.6729721845645698
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,44200,116,2.02 [1.18-3.46],0.0104257096012984
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,44750,96,1.55 [0.80-3.00],0.1944797425769311
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,43107,147,1.01 [0.57-1.78],0.9839049905160892
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,43216,256,0.76 [0.49-1.17],0.2158313292916287
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,42859,201,1.11 [0.69-1.78],0.6626279198456633
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,43504,97,2.27 [1.24-4.13],0.0075315572776151
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",42773,115,1.29 [0.69-2.42],0.4301987366207381
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,43560,148,1.08 [0.61-1.90],0.7914770982782816
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",43742,330,1.06 [0.73-1.54],0.7537198900093881
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,43164,204,1.27 [0.80-2.02],0.3164733506022011
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,42848,190,1.13 [0.68-1.86],0.6436412606409788
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,42797,139,0.73 [0.41-1.31],0.2919304516318872
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,41349,3074,1.12 [0.99-1.27],0.0622721048490083
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,43087,127,1.24 [0.69-2.25],0.4731899574489787
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,44345,700,1.25 [0.97-1.61],0.0872542287422635
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,43744,99,0.59 [0.30-1.18],0.1394827841754185
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),43925,280,1.53 [1.04-2.24],0.0322640256392223
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,44397,156,0.85 [0.49-1.48],0.5640089082246469
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,44708,198,0.96 [0.59-1.56],0.8585339779960406
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,44558,226,1.14 [0.73-1.80],0.5664257762560565
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,44353,112,1.60 [0.86-2.96],0.1360175598981942
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,44354,113,1.29 [0.68-2.44],0.4292570599815231
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,44606,1512,1.03 [0.86-1.22],0.770272806509047
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,44175,1081,1.02 [0.83-1.26],0.8337654201173907
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,43310,216,0.83 [0.52-1.32],0.4331339448100687
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,43242,148,1.35 [0.78-2.33],0.2814907250909669
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,44351,124,1.26 [0.69-2.31],0.4511192822016608
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,44600,373,1.52 [1.08-2.13],0.0161276352782253
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,44337,110,2.37 [1.36-4.14],0.00232188577702
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,All influenza,41372,200,1.47 [0.93-2.32],0.1025553733871064
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),41368,196,1.51 [0.95-2.39],0.081366819062197
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),30721,207,0.68 [0.42-1.11],0.1264298092164935
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,44573,488,0.92 [0.67-1.25],0.579724850690021
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",33139,3087,0.88 [0.78-1.00],0.0517184060133314
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",33552,3038,0.87 [0.77-0.99],0.0347347730867464
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),44086,241,1.73 [1.16-2.58],0.0072029575225963
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",41310,138,2.27 [1.42-3.64],0.0006450088272947
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Bronchiectasis,38770,605,1.19 [0.90-1.56],0.2205346446944758
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",38264,99,1.16 [0.59-2.29],0.6580863009086579
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,43015,4850,1.00 [0.91-1.11],0.9589334390458504
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",42400,129,1.39 [0.77-2.51],0.2679050977361544
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,42538,267,1.58 [1.05-2.36],0.026362612709268
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",44440,2041,1.23 [1.06-1.42],0.0064052964625895
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,42466,195,1.25 [0.77-2.03],0.361455048571912
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,41179,9043,1.15 [1.07-1.23],0.0002252406524728
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",42911,640,0.95 [0.72-1.24],0.6898509421443946
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Early onset COPD,42964,565,1.59 [1.21-2.08],0.0007943907172389
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Emphysema,38715,550,1.58 [1.22-2.06],0.0005877746029093
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,42481,510,2.51 [2.02-3.12],6.054196934690331e-17
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,44395,3223,1.43 [1.28-1.61],7.15402988778347e-10
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,42539,568,2.31 [1.85-2.88],1.0189687552042289e-13
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Later onset COPD,43007,1476,1.12 [0.94-1.33],0.2042159369462373
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,44763,527,1.12 [0.83-1.50],0.4509636554448097
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Nasal polyp,42464,193,0.97 [0.59-1.59],0.9079371821053616
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,44341,1648,1.38 [1.18-1.63],9.049266611127604e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,44374,3409,1.43 [1.28-1.60],5.754650341283698e-10
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,43729,1458,1.00 [0.83-1.19],0.9822801761934432
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other pleural conditions,41053,88,1.81 [0.92-3.56],0.083175143925843
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,44616,706,2.19 [1.78-2.69],1.1010106242522177e-13
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,44598,2244,1.30 [1.13-1.50],0.0002586776068875
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pleural effusion,42630,1665,1.43 [1.22-1.69],1.4822794985100753e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pleural plaque,41238,273,1.60 [1.09-2.33],0.0154146638551252
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",43961,2789,1.49 [1.32-1.69],1.0204979810540327e-10
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,44648,412,1.12 [0.80-1.56],0.5169680378617764
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pneumothorax,41176,211,1.05 [0.65-1.69],0.8547869108416664
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pollen allergy,44746,414,1.01 [0.72-1.41],0.9559840080587636
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,44024,114,2.46 [1.50-4.05],0.0003763394350429
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,30606,92,2.53 [1.44-4.42],0.0011788847451512
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,44305,1612,1.39 [1.18-1.64],8.277558620889956e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,42760,489,0.92 [0.67-1.25],0.578140458265785
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Viral pneumonia,41588,416,1.08 [0.78-1.50],0.6522322958261222
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",44111,343,0.95 [0.66-1.37],0.7800565877485516
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20686,189,1.21 [0.74-1.98],0.4524193436844749
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,31737,112,1.14 [0.61-2.14],0.6868475036550634
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute appendicitis,44502,248,0.78 [0.50-1.21],0.2692398159003186
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute gastritis,33779,146,0.92 [0.52-1.64],0.7829247730629728
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,41607,319,1.21 [0.83-1.77],0.3133248676505085
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute peritonitis,43962,153,1.14 [0.66-1.97],0.6397865326838206
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,43249,127,2.86 [1.80-4.54],8.39942171322558e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,34384,751,0.83 [0.64-1.07],0.1569474620962241
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",41466,178,1.00 [0.60-1.66],0.993701089904191
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",44059,178,0.98 [0.59-1.63],0.9475190161427158
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Cholecystitis,41631,343,1.23 [0.86-1.77],0.2557903399659561
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Cholelithiasis,43031,1743,1.00 [0.85-1.18],0.9546696226707172
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Chronic gastritis,34151,518,1.11 [0.82-1.51],0.4808375827653505
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,41374,86,2.26 [1.21-4.20],0.0102926064834276
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",44541,186,2.13 [1.42-3.21],0.000265499756619
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Coeliac disease,42024,210,1.03 [0.64-1.67],0.9012204359099636
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Collagenous colitis,41868,136,1.83 [1.07-3.13],0.0283800903667633
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,44508,333,0.87 [0.60-1.26],0.4530666284679545
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Constipation,44342,2806,0.96 [0.85-1.10],0.5718404590529097
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Crohn disease,41884,152,1.15 [0.66-2.01],0.6134056884948099
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",44164,108,1.09 [0.56-2.11],0.7922284080834467
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,41874,142,1.14 [0.64-2.03],0.6558449788945298
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Dental caries,43509,394,1.03 [0.73-1.45],0.8501516272338583
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,40202,3820,0.99 [0.88-1.10],0.7963836558604689
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of appendix,44566,312,0.80 [0.54-1.18],0.2616227686119408
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of liver,44579,1457,1.30 [1.09-1.55],0.0030200132461036
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",41030,7397,1.10 [1.02-1.19],0.0179381269961753
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",44062,947,1.16 [0.93-1.44],0.1930314155075509
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,44636,827,1.04 [0.82-1.31],0.7718880340495088
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,43311,196,1.36 [0.85-2.19],0.2008862388794314
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,43064,108,1.04 [0.54-2.00],0.8977584246799618
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,44257,2443,1.15 [1.00-1.32],0.0428492918024077
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of tongue,43079,190,0.81 [0.49-1.35],0.4211929230806071
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",43730,2442,1.07 [0.93-1.22],0.3711110337595191
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,37085,5460,0.85 [0.77-0.94],0.0008074357221892
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,33968,335,1.21 [0.83-1.75],0.3185499925030114
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",44634,265,1.33 [0.89-1.99],0.1613506373192144
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,44637,92,1.05 [0.51-2.16],0.9046592600315354
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,43344,222,1.89 [1.27-2.82],0.0017264786577138
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,31882,257,1.01 [0.67-1.55],0.9495817724847222
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,34577,944,0.91 [0.73-1.14],0.4290268829440748
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastric ulcer,34250,617,1.21 [0.92-1.60],0.1655020325471316
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,37924,4291,1.08 [0.97-1.20],0.1523226198876113
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,34550,917,1.17 [0.94-1.47],0.1664119181327491
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,34693,14280,1.02 [0.96-1.08],0.536609704670059
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,GI-bleeding,43797,1983,1.18 [1.01-1.37],0.0340458906235612
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,43221,106,1.30 [0.68-2.48],0.4287719780521637
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,33293,2165,0.92 [0.79-1.07],0.2640986760582875
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",43227,105,2.35 [1.39-3.98],0.0013812492137907
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Hernia,41951,5569,0.97 [0.88-1.06],0.5045287363519102
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Impacted teeth,44649,87,1.16 [0.55-2.44],0.6872017263717741
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Impaction of intestines,31724,99,1.09 [0.54-2.18],0.8182604448635884
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Inguinal hernia,37936,1554,0.93 [0.78-1.11],0.4316444652546798
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",36557,175,0.91 [0.54-1.54],0.7369291520889919
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,31792,167,1.26 [0.75-2.12],0.3802751179120854
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,42062,248,1.00 [0.64-1.55],0.983694708798512
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,32580,955,1.01 [0.80-1.26],0.9462319261313334
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,44738,627,1.14 [0.87-1.49],0.3377471136589657
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,43032,1300,1.16 [0.96-1.40],0.1206720572427745
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,43459,1727,1.17 [0.99-1.38],0.0621052522076316
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,33952,319,1.14 [0.77-1.67],0.5121522086268598
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oesophagitis,34680,1047,1.11 [0.90-1.37],0.3247945768965974
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,44696,239,1.61 [1.05-2.46],0.0280773041745222
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,36499,117,1.12 [0.60-2.11],0.7190278949488917
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,33981,2356,1.00 [0.86-1.15],0.9464603639123328
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,41770,482,1.08 [0.79-1.47],0.6211630426970287
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,41558,270,0.92 [0.60-1.40],0.6972152170699584
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,34657,3032,0.96 [0.85-1.09],0.5380779270466294
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,41308,9683,0.96 [0.90-1.03],0.2600299060225147
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,43049,362,1.29 [0.90-1.84],0.1615648709612161
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of liver,44312,1190,1.29 [1.06-1.56],0.0095103063066854
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,34781,1148,0.89 [0.72-1.09],0.259768852903516
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,41539,251,0.95 [0.61-1.46],0.8016719004151929
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,44524,715,1.05 [0.81-1.36],0.7105321302885979
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,35257,1624,1.11 [0.94-1.32],0.2251465958021875
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,43822,2008,1.16 [1.00-1.35],0.0480686760268474
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,43419,304,0.99 [0.67-1.47],0.9713044280130592
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,34513,2888,0.96 [0.85-1.09],0.5439677363142283
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),37085,3452,1.11 [0.99-1.25],0.0760027481225404
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,43296,174,1.50 [0.92-2.45],0.1011513270342267
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,43250,1518,1.24 [1.04-1.48],0.0140087333620129
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",32217,592,1.41 [1.07-1.84],0.0135088813383888
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,44619,109,0.91 [0.46-1.77],0.770624634561299
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,32475,850,1.23 [0.98-1.55],0.0762647286521748
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",42081,267,1.16 [0.77-1.75],0.4857490811187847
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,44765,100,1.67 [0.87-3.19],0.122141451475866
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,43123,203,1.46 [0.91-2.33],0.1136084064620952
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Toxic colitis,41827,95,2.39 [1.39-4.11],0.0016513939510315
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,34102,469,1.15 [0.84-1.58],0.382423248044656
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,42011,279,0.91 [0.60-1.39],0.6699579559393041
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",41965,233,1.25 [0.80-1.95],0.3295988352905002
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Umbilical hernia,36848,466,0.59 [0.43-0.81],0.0012559429263734
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,31927,302,1.08 [0.72-1.60],0.7188402552150581
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ventral hernia,36829,447,1.56 [1.14-2.13],0.004879520465078
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Volvulus,31764,139,0.88 [0.49-1.59],0.6799157018880568
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,44656,495,1.46 [1.09-1.96],0.0120132781442748
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,44236,135,1.54 [0.87-2.72],0.1343833311534831
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,41292,281,1.77 [1.19-2.62],0.004481178909691
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,43667,1198,1.46 [1.21-1.77],7.498058520299148e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",42774,305,1.70 [1.18-2.44],0.0046836879114597
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,41672,661,1.81 [1.43-2.29],7.350194630147078e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,44253,482,1.38 [1.02-1.86],0.036537407159977
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,44601,830,1.28 [1.02-1.62],0.0353116566302354
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,43855,84,0.57 [0.27-1.24],0.1556659938145327
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,42081,5488,1.33 [1.21-1.45],1.0312525559894803e-09
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,43993,755,1.27 [0.99-1.62],0.0583087763166303
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,43764,526,1.16 [0.87-1.56],0.3136202637212797
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,44090,1621,1.53 [1.30-1.80],2.2833055078460094e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",44758,93,1.25 [0.62-2.53],0.538105429946698
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,41121,110,0.46 [0.24-0.90],0.0223740683620441
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,43330,92,2.02 [1.10-3.70],0.0229611397989808
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,44235,464,1.40 [1.03-1.90],0.0320441472545981
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,41795,784,1.19 [0.93-1.51],0.1689997076301213
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,41124,113,2.04 [1.18-3.51],0.0106120492559248
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,44637,140,1.73 [1.02-2.94],0.0409598814105462
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,42773,304,1.71 [1.19-2.46],0.0037167807921826
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,44431,330,1.24 [0.86-1.80],0.2520429552215439
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,43872,101,1.42 [0.75-2.69],0.2768324617178196
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,41123,112,0.64 [0.33-1.25],0.1951924800171224
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,43794,2783,1.44 [1.28-1.64],6.168693992517543e-09
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",41862,851,1.25 [0.99-1.58],0.0564296006747293
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,41131,120,1.79 [1.02-3.15],0.041715342309097
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,44634,533,1.25 [0.93-1.68],0.1312384946023964
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,43891,120,2.09 [1.22-3.58],0.0075187850004389
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,44538,437,1.23 [0.89-1.70],0.2093775169542484
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,44698,537,1.45 [1.10-1.93],0.0094239808132186
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,41233,222,1.88 [1.21-2.90],0.00465740161055
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,41474,463,1.09 [0.79-1.50],0.6029065148381952
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,44681,520,1.43 [1.07-1.91],0.014643012317669
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",41400,389,2.61 [2.02-3.35],1.0231435410999676e-13
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,44731,234,1.62 [1.07-2.47],0.0237613520627802
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,38420,190,1.08 [0.66-1.78],0.7587799148220109
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,40755,9728,1.06 [0.99-1.14],0.1136808180445424
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,38314,7287,1.07 [0.99-1.16],0.0950968367843381
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,38363,133,1.20 [0.67-2.16],0.5466678595860857
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,38853,259,1.63 [1.08-2.44],0.0185842102201137
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,38900,306,1.52 [1.04-2.21],0.0307001070556185
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,44358,160,2.19 [1.36-3.53],0.0013392733413776
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",38763,169,1.08 [0.63-1.83],0.7850684110400534
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,32991,1964,1.21 [1.04-1.42],0.0160913383652247
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",44538,331,0.86 [0.59-1.27],0.4498724777525003
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,39336,742,1.16 [0.90-1.49],0.2444362403560358
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37852,12548,1.09 [1.02-1.16],0.0086787008090787
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,41366,204,1.47 [0.93-2.33],0.1018736817021315
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,38492,262,0.86 [0.56-1.32],0.4949707816453137
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,39230,1000,1.00 [0.80-1.25],0.9889799499800244
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,43155,4561,1.08 [0.97-1.19],0.1501591695454873
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,38710,480,1.05 [0.77-1.44],0.7513432869547203
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,38621,391,1.29 [0.91-1.83],0.1497263802210006
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,38471,241,0.87 [0.56-1.37],0.5616447156192106
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,43631,123,0.84 [0.45-1.57],0.5762955066660764
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,33928,2901,1.05 [0.92-1.19],0.4796670777252585
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,32030,1003,1.17 [0.94-1.45],0.1578984315515464
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",44655,987,1.09 [0.88-1.34],0.4347399745490935
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,31160,133,1.15 [0.62-2.11],0.6623927616809162
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),31612,585,1.00 [0.75-1.34],0.9905614594306292
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,38755,525,0.93 [0.69-1.26],0.6266113652086867
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,32133,1106,0.88 [0.71-1.08],0.2249117813664442
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,38686,92,1.62 [0.83-3.17],0.1604796362814157
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,39672,1078,1.05 [0.85-1.29],0.657575772242811
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,39110,516,0.93 [0.68-1.26],0.6414045426866699
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,32055,1028,0.87 [0.70-1.08],0.209405026136179
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,38361,131,0.77 [0.42-1.41],0.3938626749593991
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",38332,102,1.11 [0.56-2.18],0.7721555965833056
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,41283,121,1.34 [0.74-2.42],0.3396678824821323
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,44115,2953,1.14 [1.00-1.29],0.0466061138162507
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,43102,1940,1.15 [0.99-1.35],0.0756959596586537
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",44536,777,1.37 [1.08-1.74],0.008440840561043
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,35331,4304,1.17 [1.06-1.30],0.0026784436428377
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,31134,107,0.44 [0.22-0.88],0.0194060027330105
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,38388,158,1.23 [0.72-2.11],0.4533270280830186
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,31119,92,2.20 [1.15-4.21],0.0167276727682687
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),31246,219,1.71 [1.09-2.68],0.0195630556261251
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,41581,419,1.20 [0.86-1.67],0.2800226358644867
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,41803,641,1.25 [0.95-1.64],0.1049852138318736
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,44733,171,1.89 [1.19-3.02],0.0074114694461001
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",41686,3092,1.09 [0.96-1.23],0.1658716221103087
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,38402,172,1.48 [0.89-2.47],0.1318868341346177
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),31272,245,1.31 [0.84-2.04],0.2305551689096462
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,39838,1244,0.98 [0.80-1.19],0.8044728924876028
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,34744,3717,1.06 [0.94-1.18],0.3537971273276581
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,43670,162,1.00 [0.58-1.71],0.9907135718872646
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,44754,128,1.54 [0.86-2.74],0.1466160778265581
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,38368,138,1.44 [0.82-2.53],0.2002119191471068
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",40360,2130,1.14 [0.98-1.32],0.0855963280615086
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,38381,151,1.09 [0.62-1.90],0.7695712145692806
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,33830,2803,1.11 [0.97-1.26],0.1176300333226003
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,41363,201,0.71 [0.43-1.16],0.1711211462247858
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,38316,86,0.90 [0.42-1.92],0.7893944723843086
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,38869,275,0.97 [0.64-1.47],0.8840291650276102
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,39156,926,1.16 [0.93-1.44],0.2028262296462762
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,44130,622,0.90 [0.68-1.20],0.4806091702272151
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,39575,981,1.26 [1.01-1.56],0.0363651663203686
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,44556,756,1.38 [1.09-1.75],0.0085506572498556
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,44748,91,1.09 [0.53-2.23],0.8236357812812036
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,38559,329,0.98 [0.67-1.43],0.9096569578677126
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,35456,1297,1.11 [0.91-1.34],0.2979145464255437
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,39214,984,1.04 [0.84-1.30],0.7043835080592918
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],38629,399,1.29 [0.92-1.82],0.1365135152044859
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",31127,100,0.94 [0.47-1.90],0.8641736673272145
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,35305,4278,1.17 [1.05-1.30],0.0034001273780169
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,32151,1124,1.16 [0.94-1.42],0.1595533366201278
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,43909,401,0.92 [0.65-1.30],0.6507473385906262
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",44670,108,2.24 [1.30-3.88],0.0037612333842637
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",41061,84,0.80 [0.38-1.69],0.565938522462893
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,31158,131,1.67 [0.93-2.99],0.08372860213779
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,38770,176,0.95 [0.56-1.61],0.8527167684621484
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,31815,788,1.40 [1.10-1.78],0.0057513728432504
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,38766,536,1.02 [0.76-1.36],0.9208823320444266
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,39029,435,1.01 [0.73-1.40],0.9511696886301152
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,38912,318,1.18 [0.80-1.73],0.4014280719993522
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,35037,103,2.22 [1.25-3.93],0.0063550723657436
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",44755,98,1.33 [0.67-2.61],0.4116961497829478
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,39250,1020,1.09 [0.88-1.35],0.4436971735043109
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],43673,165,0.75 [0.43-1.29],0.2939484697207787
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,42680,4450,1.05 [0.95-1.16],0.3509716071044944
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",38460,230,1.00 [0.63-1.58],0.994567423541736
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,39507,913,1.03 [0.82-1.29],0.8282264942371206
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,42307,403,1.04 [0.74-1.47],0.8078926984606388
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,38932,338,1.16 [0.80-1.68],0.4269179251139123
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,41244,2650,1.07 [0.93-1.22],0.3408175373946899
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,40328,1734,1.17 [0.99-1.38],0.0584083109410145
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],38319,89,2.15 [1.14-4.04],0.0175316040536462
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,43760,252,0.99 [0.64-1.53],0.9633409975549672
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,38518,288,1.08 [0.72-1.63],0.7078102627633183
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,38366,136,1.07 [0.59-1.94],0.8192001547039018
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),31121,94,1.71 [0.87-3.36],0.119125841548416
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,43169,2588,1.39 [1.23-1.58],2.758373117662911e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18108,87,0.88 [0.41-1.86],0.7294945054964654
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23610,101,1.06 [0.52-2.14],0.8716929310864148
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,44239,548,0.99 [0.74-1.33],0.9527228763055992
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,43838,147,0.91 [0.52-1.59],0.743018010987919
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,42910,2329,1.20 [1.04-1.37],0.0106873445580548
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,44440,109,1.35 [0.73-2.49],0.3325227966219902
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,44406,504,1.32 [0.99-1.77],0.0577000327993157
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Cystitis,39546,401,1.08 [0.76-1.52],0.6670393183103747
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Dialysis,40692,111,1.15 [0.61-2.15],0.661664053171293
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19486,2854,0.99 [0.87-1.12],0.878921301937665
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23797,288,1.48 [0.99-2.21],0.0562494643082239
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,18172,151,1.03 [0.58-1.82],0.9279826971909644
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18364,343,0.66 [0.46-0.97],0.0344709884791161
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18904,883,1.02 [0.80-1.29],0.8863474328073631
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,37412,9142,1.08 [1.01-1.16],0.0322988145173747
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,44459,128,1.62 [0.93-2.79],0.0855937770786655
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,16811,179,0.93 [0.56-1.54],0.7739428275928549
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,40528,479,0.96 [0.70-1.31],0.7757882457510216
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18872,2240,0.97 [0.84-1.12],0.6559710251031383
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23732,349,1.12 [0.77-1.62],0.5556615270979799
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16830,198,1.49 [0.94-2.35],0.08850890680248
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,23811,110,0.32 [0.17-0.62],0.0007173650606733
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18290,269,0.89 [0.58-1.36],0.579836469603293
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,39275,130,0.87 [0.47-1.61],0.6644114698489376
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,20177,2156,0.95 [0.82-1.11],0.5262641319056793
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16727,95,1.39 [0.72-2.70],0.3299983499862121
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18143,122,1.20 [0.63-2.28],0.5715290363850712
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",44770,112,1.30 [0.69-2.43],0.419757015651013
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",44770,116,0.90 [0.47-1.72],0.7513333036121542
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,42973,3828,1.12 [1.00-1.25],0.0487388669816123
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,40391,1246,1.09 [0.90-1.33],0.3574514137339627
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23608,99,2.20 [1.16-4.15],0.01516441667185
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,44678,776,1.12 [0.88-1.42],0.3682417975644632
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16896,264,0.62 [0.40-0.94],0.0247751941614775
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16877,245,1.35 [0.89-2.04],0.1588352239512714
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16827,195,0.79 [0.48-1.28],0.3376424748863745
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,44720,118,0.86 [0.45-1.64],0.6504781600206344
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,42061,2916,1.23 [1.08-1.39],0.0011739545685755
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23565,182,1.17 [0.70-1.96],0.5473949989513103
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18159,138,1.65 [0.92-2.96],0.0906880215855145
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18367,346,0.79 [0.54-1.15],0.2159276042865849
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18125,104,0.90 [0.44-1.82],0.7715591373170381
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18204,183,0.56 [0.33-0.95],0.0317520438231639
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,40608,559,1.06 [0.80-1.42],0.6846605440313507
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,44159,257,0.89 [0.58-1.36],0.5759011384638258
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18288,267,1.13 [0.73-1.74],0.5889913343342503
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18114,93,1.18 [0.56-2.47],0.6705728013117915
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18588,567,1.04 [0.78-1.40],0.7808178105141155
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,18163,142,0.77 [0.42-1.41],0.3986676587533796
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18541,520,1.18 [0.87-1.60],0.2894838277541296
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,44420,89,0.90 [0.43-1.86],0.7731583072215162
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16863,231,1.43 [0.93-2.19],0.1020989557360132
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,44415,4366,1.22 [1.11-1.35],8.711392290162102e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",40250,201,1.72 [1.09-2.71],0.0199518837514809
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,40780,199,1.24 [0.78-1.99],0.3615327199276662
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,43787,96,1.11 [0.56-2.21],0.7554287091371481
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,39527,382,0.97 [0.69-1.38],0.8814141798657473
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,44375,684,1.05 [0.81-1.36],0.7316928705260579
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18144,123,1.36 [0.73-2.55],0.3356419647691543
